Sennosides And Docusate Sodium Tablet
NDC Package 69618-065-01
Package Information
Sennosides And Docusate Sodium (sennosides, docusate sodium) tablets is take preferably at bedtime or as directed by a doctordo not exceed maximum dosageagestarting dosagemaximun dosageadults and children 12 years of age or older2 tablets once a day4 tablets twice a daychildren 6 to under 12 years1 tablet once a day2 tablets twice a daychildren 2 to under 6 years1/2 tablet once a day1 tablet twice a daychildren under 2 yearsask a doctorask a doctor. This formulation utilizes a tablet delivery system. Marketed by Reliable-1 Laboratories Llc, this product is identified by NDC 69618-065 and is authorized under FDA application M007.
Identification & Billing
- RxCUI: 998740 - sennosides 8.6 MG / docusate sodium 50 MG Oral Tablet
- RxCUI: 998740 - docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet
- RxCUI: 998740 - DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 69618 - Reliable-1 Laboratories Llc
- 69618-065 - Sennosides And Docusate Sodium
- 69618-065-01 - 100 TABLET in 1 BOTTLE
- 69618-065 - Sennosides And Docusate Sodium
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 69618-065-01 identifies a specific commercial package of 100 tablet in 1 bottle of Sennosides And Docusate Sodium, a human over the counter drug labeled by Reliable-1 Laboratories Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 100 billable units per package. This tablet is formulated for oral use and contains docusate sodium; sennosides as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Reliable-1 Laboratories Llc on August 01, 2020. The current certification is valid through December 31, 2026.
How is this Reliable-1 Laboratories Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 69618006501. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.